US › Healthcare

Alpha Cognition Inc (ACOG)

US · Healthcare · Biotechnology

$8.85+5.36%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$6.1M

Revenue YoY

+267.6%

Net profit

$-8.8M

EPS

$-0.40

EPS estimate

$-0.39

Net margin

-144.3%

EPS came in at -0.40 against a street estimate of -0.39 — a miss of 2.6%.

Key statistics

Market cap

$191.6M

Forward P/E

26.9

P/B

3.55

Book value

$2.43

EPS (TTM)

$-0.99

52-week high

$10.14

52-week low

$4.50

50-day MA

$8.78

200-day MA

$6.68

Beta

2.24

Analyst view

Analysts rate Alpha Cognition Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $18.00.

Shareholding

Insiders

5.33%

Institutions

53.34%

Largest institutional holders

Fund	Stake
Opaleye Management Inc	13.30%
Solas Capital Management LLC	8.84%
Awm Investment Company Inc	7.68%
Cable Car Capital LLC	6.35%
Ikarian Capital, LLC	4.85%
Sphera Funds Management Ltd.	2.61%
Alyeska Investment Group, L.P.	1.68%
BOOTHBAY FUND MANAGEMENT, LLC	1.18%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alpha Cognition Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.